chitosan has been researched along with Acinetobacter Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Aliakbar Ahovan, Z; Brouki Milan, P; Eftekhari, BS; Eftekhari, S; Gholipourmalekabadi, M; Hashemi, A; Khosravimelal, S; Mehrabi, S; Mobaraki, M; Seifalian, AM | 1 |
Chen, S; Deng, K; Du, X; Feng, G; Huang, Y; Jiang, M; Li, Z; Lin, S; Shen, Z; Shu, L; Xu, H; Xue, J; Yao, J | 1 |
Costa, EM; Pintado, MM; Silva, S; Tavaria, FK; Veiga, M | 1 |
Azevedo, MM; Cobrado, L; Pina-Vaz, C; Rodrigues, AG; Silva-Dias, A | 1 |
4 other study(ies) available for chitosan and Acinetobacter Infections
Article | Year |
---|---|
Thermo-responsive chitosan hydrogel for healing of full-thickness wounds infected with XDR bacteria isolated from burn patients: In vitro and in vivo animal model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Load; Bandages, Hydrocolloid; Burns; Cell Adhesion; Cells, Cultured; Chitosan; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Drug Stability; Fibroblasts; Humans; Hydrogels; Materials Testing; Rats; Rats, Sprague-Dawley; Wound Healing; Wound Infection | 2020 |
A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
Topics: A549 Cells; Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Animals; Antibodies, Bacterial; Bacterial Load; Bacterial Vaccines; Body Weight; Chitosan; Epitopes; Female; Humans; Immunity, Humoral; Immunization; Immunoglobulin G; Interferon-gamma; Interleukin-4; Lung; Mice; Mice, Inbred BALB C; Nanoparticles; Peptides; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Proteins; Spleen; Survival Analysis | 2021 |
Exploring chitosan nanoparticles as effective inhibitors of antibiotic resistant skin microorganisms - From in vitro to ex vitro testing.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Cell Line; Chitosan; Drug Resistance, Bacterial; Humans; Keratinocytes; Nanoparticles; Skin Diseases, Bacterial | 2018 |
In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Infective Agents; Biofilms; Candida albicans; Candidiasis; Catheter-Related Infections; Cerium; Chitosan; Female; Gallic Acid; Hexoses; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcus epidermidis | 2013 |